Radial artery or saphenous vein for coronary artery bypass grafting |
| |
| Affiliation: | 1. Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA;2. Department of Thoracic and Cardiovascular Surgery, Allegheny General Hospital, Pittsburgh, PA, USA;1. Department of Cardiac Surgery, Lankenau Heart Institute, Lankenau Medical Center, Main Line Health, 100 East Lancaster Avenue, Suite 215, Wynnewood, PA 19096;2. Department of Cardiac Surgery Research, Lankenau Institute for Medical Research, Main Line Health, Wynnewood, PA;1. School of Pharmacy & Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK;2. Liverpool Centre for Cardiovascular Science, Liverpool, UK;1. Department of Medicine, University of North Carolina, Chapel Hill, NC, United States;2. Division of Cardiology, University of North Carolina, Chapel Hill, NC, United States |
| |
| Abstract: | Coronary artery disease (CAD) is the most common cardiovascular disease worldwide, affecting over 18 million American adults. Coronary artery bypass grafting (CABG) is the standard of care for patients with left main or triple vessel CAD. Historically, the saphenous vein (SV) has been utilized to bypass the majority of the coronary vessels in patients undergoing CABG, but more recent data suggest that the use of the radial artery (RA), rather than the SV, is associated with improved cardiac outcomes and better survival. The aim of this review is to summarize the current literature on the use of RA and SV for CABG in patients with multivessel CAD. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
